Novel fluorine-18 PET radiotracers based on flumazenil for GABAA imaging in the brain

被引:11
|
作者
Rodnick, Melissa E. [1 ]
Hockley, Brian G. [1 ]
Sherman, Phillip [1 ]
Quesada, Carole [1 ]
Battle, Mark R. [2 ]
Jackson, Alexander [2 ]
Linder, Karen E. [3 ]
Macholl, Sven [2 ]
Trigg, William J. [2 ]
Kilbourn, Michael R. [1 ]
Scott, Peter J. H. [1 ,4 ]
机构
[1] Univ Michigan, Sch Med, Div Nucl Med, Dept Radiol, Ann Arbor, MI 48109 USA
[2] GE Healthcare, Grove Ctr, Amersham, Bucks, England
[3] GE Healthcare, Carnegie Ctr 101, Princeton, NJ USA
[4] Univ Michigan, Interdept Program Med Chem, Ann Arbor, MI USA
基金
美国国家卫生研究院;
关键词
PET; Neurology; Benzodiazepine; Radiopharmaceutical synthesis; BENZODIAZEPINE RECEPTORS; 15-1788; BINDING; INHIBITION; MONKEY;
D O I
10.1016/j.nucmedbio.2013.06.004
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Introduction: Two 7-fluoroimidazobenzodiazepines (AH114726 and GEH120348), analogs of flumazenil, were labeled with fluorine-18 and evaluated as alternative radioligands for in vivo imaging of the GABA(A)/benzodiazepine receptor by comparing them to [C-11]flumazenil in rhesus monkey. Methods: Radiotracers were prepared from the corresponding nitro-precursors in an automated synthesis module, and primate imaging studies were conducted on a Concorde MicroPET P4 scanner. The brain was imaged for 60 (12 x 5 min frames) or 90 min (18 x 5 min frames), and data was reconstructed using the 3D MAP algorithm. Specificity of [F-18]AH114726 and [F-18]GEH120348 was confirmed by displacement studies using unlabeled flumazenil. Results: [F-18]GEH120348 and [F-18]AH114726 were obtained in 13-24% yields (end of synthesis) with high chemical (>95%) and radiochemical (>99%) purities, and high specific activities (2061 +/- 985 Ci/mmol). The in vivo pharmacokinetics of [F-18]AH114726 and [F-18]GEH120348 were determined in a non-human primate and directly compared with [C-11]flumazenil. Both fluorine-18 radioligands showed time-dependent regional brain distributions that correlated with the distribution of [C-11]flumazenil and the known concentrations of GABA(A)/benzodiazepine receptors in the monkey brain. [F-18]AH114726 exhibited maximal brain uptake and tissue time-radioactivity curves that were most similar to [C-11]flumazenil. In contrast, [F-18]GEH120348 showed higher initial brain uptake but very different pharmacokinetics with continued accumulation of radioactivity into the cortical regions of high GABA/benzodiazepine receptor concentrations and very little clearance from the regions of low receptor densities. Rapid washout of both radiotracers occurred upon treatment with unlabeled flumazenil. Conclusion: The ease of the radiochemical synthesis, together with in vivo brain pharmacokinetics most similar to [C-11]flumazenil, support that [F-18]AH114726 is a suitable option for imaging the GABA(A) receptor. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:901 / 905
页数:5
相关论文
共 50 条
  • [1] The development of potential new fluorine-18 labelled radiotracers for imaging the GABAA receptor
    Jackson, Alexander
    Guilbert, Benedicte B.
    Plant, Stuart D.
    Goggi, Julian
    Battle, Mark R.
    Woodcraft, John L.
    Gaeta, Alessandra
    Jones, Clare L.
    Bouvet, Denis R.
    Jones, Paul A.
    O'Shea, Dennis M.
    Zheng, Penny Hao
    Brown, Samantha L.
    Ewan, Amanda L.
    Trigg, William
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (03) : 821 - 826
  • [2] Synthetic methodologies and PET imaging applications of fluorine-18 radiotracers: a patent review
    Nerella, Sridhar Goud
    Bhattacharya, Ahana
    Thacker, Pavitra S.
    Tulja, Sanam
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2022, 32 (04) : 455 - 473
  • [3] PET imaging of musculoskeletal tumours with fluorine-18 α-methyltyrosine: comparison with fluorine-18 fluorodeoxyglucose PET
    Hideomi Watanabe
    Tomio Inoue
    Tetsuya Shinozaki
    Takashi Yanagawa
    Adel Refaat Ahmed
    Katsumi Tomiyoshi
    Noboru Oriuchi
    Mari Tokunaga
    Jun Aoki
    Keigo Endo
    Kenji Takagishi
    [J]. European Journal of Nuclear Medicine, 2000, 27 : 1509 - 1517
  • [4] PET imaging of musculoskeletal tumours with fluorine-18 α-methyltyrosine:: comparison with fluorine-18 fluorodeoxyglucose PET
    Watanabe, H
    Inoue, T
    Shinozaki, T
    Yanagawa, T
    Ahmed, AR
    Tomiyoshi, K
    Oriuchi, N
    Tokunaga, M
    Aoki, J
    Endo, K
    Takagishi, K
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2000, 27 (10) : 1509 - 1517
  • [5] A novel fluorine-18 PET radiotracer for imaging sigma-1 receptor in the brain
    Fan, Jinda
    Yu, Lihai
    Padakanti, Prashanth
    Zhou, Haiying
    Pamu, Sreedhar
    Li, Shihong
    Parsons, Stanley
    Mach, Robert
    Permutters, Joel
    Tu, Zhude
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [6] New classes of fluorine-18 labelled radiotracers for imaging dementia
    Vasdev, Neil
    Kulkarni, Padmakar
    van Oosten, Erik
    Cao, Pengpeng
    Chio, Jason
    Nitz, Mark
    McLaurin, JoAnne
    Houle, Sylvain
    Wilson, Alan
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [7] Fluorine-18 Labelled substrate-based radiotracers for in vivo imaging of lysyl oxidase
    Kuchar, Manuela
    Wodtke, Robert
    Lenk, Jens
    Bergmann, Ralf
    Mosch, Birgit
    Steinbach, Joerg
    Pietzsch, Jens
    Loeser, Reik
    [J]. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2013, 56 : S398 - S398
  • [8] Novel Fluorine-18 Labeled Benzothiazole Derivatives for Amyloid Imaging by PET
    Furumoto, S.
    Kawauchi, T.
    Okamura, N.
    Tago, T.
    Harada, R.
    Zhang, M. R.
    Maruyama, M.
    Higuchi, M.
    Yanai, K.
    Iwata, R.
    Kudo, Y.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S168 - S168
  • [9] The traceless Staudinger ligation with fluorine-18: a novel and versatile labeling technique for the synthesis of PET-radiotracers
    Pretze, Marc
    Wuest, Frank
    Peppel, Tim
    Koeckerling, Martin
    Mamat, Constantin
    [J]. TETRAHEDRON LETTERS, 2010, 51 (49) : 6410 - 6414
  • [10] Fluorine-18 DOPA PET imaging of paraganglioma syndrome
    Brink, I
    Schaefer, O
    Waz, M
    Neumann, HPH
    [J]. CLINICAL NUCLEAR MEDICINE, 2006, 31 (01) : 39 - 41